"Humoral Immune Responses to West Nile Virus (WNV) and High-Throughput Identification of Patient-Derived Monoclonal Antibodies"

Dr. Lingling Xu earned her M.S. in Microbiology from Nankai University before completing her Ph.D. at the University of Georgia in 2022. She is currently a postdoctoral fellow in the Wrammert Lab, where her research focuses on the humoral immune response to flavivirus infections. Her work investigates the dual roles of cross-reactive antibodies in protection and pathogenesis, as well as the high-throughput discovery of therapeutic monoclonal antibodies.